Q2 2019 Neogenomics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the NeoGenomics Second Quarter 2019 Earnings Call. (Operator Instructions)
At this time, it's my pleasure to turn the floor over to Mr. Doug VanOort, Chief Executive Officer. Sir, the floor is yours.
Well, thank you, Tom. Good morning, everyone. I'd like to welcome you to NeoGenomics Second Quarter 2019 Conference Call.
Joining me from our Fort Myers headquarters is Sharon Virag, our Chief Financial Officer; George Cardoza, President of our Pharma Services Division; and Bill Bonello, Chief Strategy and Corporate Development Officer and Director of Investor Relations.
Dr. Larry Weiss, our Chief Scientific Officer, is dialing in from California; and Rob Shovlin, President of our Clinical Services Division, is on vacation today.
Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |